Will Promising New Malaria Vaccine Deliver? Nov 6, 2009
Extending the Malaria Vaccine to Far Reaches of Africa - ABC News ... Will Promising New Malaria Vaccine Deliver ... The Path Malaria Initiative, funded by the Bill and Melinda Gates Foundation and the pharmaceutical company GlaxoSmithKline, says it is taking unprecedented measures to try and ensure that countries will be ready to distribute the malaria vaccine, called RTSS, as soon as it's approved. (ABC News)
Africa: Continent to Benefit From World's Largest Malaria Vaccine Trial Nov 5, 2009
com: Africa: Continent to Benefit From World's Largest Malaria Vaccine Trial (Page 1 of 1) ... Continent to Benefit From World's Largest Malaria Vaccine Trial ... New York A pivotal efficacy trial of RTS,S, the world's most clinically advanced malaria vaccine candidate, is now underway in seven African countries: Burkina Faso, Gabon, Ghana, Kenya, Malawi, Mozambique and Tanzania, a statement made available to Leadership Correspondent in New York has said. (allAfrica.com)
Africa: Malaria Vaccine Draws Closer Nov 5, 2009
com: Africa: Malaria Vaccine Draws Closer (Page 1 of 1). Malaria Vaccine Draws Closer ... Nairobi After 20 years of trials, scientists have announced they are on the threshold of discovering a malaria vaccine. (allAfrica.com)
World largest malaria vaccine trial underway in Africa Nov 4, 2009
NAIROBI, Nov. 4 (Xinhua) -- A pivotal efficacy trial of RTS,S, the world's most clinically advanced malaria vaccine candidate, is now underway in seven African countries ... The health experts were optimistic that the malaria vaccine could be made available to African governments by the year 2012 ... GlaxoSmithKline Biologicals' (GSK Bio) RTS,S is the first malaria vaccine candidate to demonstrate significant efficacy during early development to warrant Phase III testing. (Xinhuanet, China)
First malaria vaccine 'ready in 3-5 years' Nov 4, 2009
First malaria vaccine 'ready in 3-5 years ... The most clinically advanced malaria vaccine so far should be ready for use in three to five years after Phase three trials began in May, researchers have said ... NAIROBI (AFP) - The most clinically advanced malaria vaccine so far should be ready for use in three to five years after Phase three trials began in May, researchers said Tuesday. (Yahoo! Asia News)
World's largest malaria vaccine trial now underway in 7 African countries Nov 3, 2009
NAIROBI, KENYA November 3, 2009 A pivotal efficacy trial of RTS,S, the world's most clinically advanced malaria vaccine candidate, is now underway in seven African countries: Burkina Faso, Gabon, Ghana, Kenya, Malawi, Mozambique and Tanzania ... GlaxoSmithKline Biologicals' (GSK Bio) RTS,S is the first malaria vaccine candidate to demonstrate significant efficacy during early development to warrant Phase III testing ... It is the leading vaccine candidate in the global effort by the PATH... (EurekAlert!)
Contests increasingly a top draw for innovators seeking challenge, recognition Nov 2, 2009
Senator Bernie Sanders of Vermont is pushing for a government-sponsored prize to encourage medical breakthroughs in areas that do not typically attract enough private industry investment, such as the development of a malaria vaccine. On a White House blog, Kalil is soliciting suggestions from citizens for competitions that the administration should support. (Boston Globe)
A year on the road Oct 29, 2009
There is no malaria vaccine. Pills to prevent infection have side effects, but if you get infected, you can take a heavier dose of the same drug. (MSNBC -- Travel)
Can Innovation Save the Economy? Oct 14, 2009
In June, (GSK) for a new malaria vaccine, which includes an adjuvant provided by Antigenics. Shares in Antigenics have soared over 300 percent so far this year. (Slate)
Sanaria Inc. Receives Multi-Year U.S. NIH Phase II Small Business Innovation Research Grant to Enhance Efficiency and Scale-up of its Malaria Vaccine Manufacturing Process Sep 16, 2009
The company's primary mission is to develop and commercialize attenuated whole-parasite malaria vaccines that confer high-level, long-lasting protection against Plasmodium falciparum, the parasite responsible for most of the malaria-associated severe illness and death worldwide. Sanaria's corporate headquarters, administrative, research, development, and manufacturing operations are located in Rockville, Maryland. (PR Newswire)
Structures put in place to support vaccine use in Africa Sep 4, 2009
Kintampo, (B/A), Sept. 4, GNA - A local and international taskforce has been set up in preparation for the licensure and use of the experimental RTS,S malaria vaccine being tested in Ghana and across Africa ... Dr Asante was speaking to the GNA in Kintampo after the launch of a phase three studies at KHRC. It is the final trial that would see the licensure and use of the RTS,S malaria vaccine to control malaria in Africa ... The trial is being sponsored by the Gates Foundation through the... (Ghana Web, Ghana)
African scientists in final race to outdoor malaria vaccine Sep 3, 2009
The ultimate aim of the Phase Three study is to develop a malaria vaccine that can be given to infants as part of the Expanded Programme of Immunization to offer protection against malaria ... Dr Araon Offei, the Brong-Ahafo Regional Director of Health Services, said the search for a malaria vaccine to protect children and pregnant women had been a long drawn out war ... He said it was the hope that one day a malaria vaccine would be found to work as other vaccines had for the six killer... (Ghana Web, Ghana)
First Genetically-engineered Malaria Vaccine To Enter Human Trials Aug 25, 2009
"We believe that our genetically attenuated parasite approach provides a safe and reproducible way of developing a whole organism malaria vaccine.". Professor Cowman said it was unlikely the weakened parasites used in the vaccine would regain their potency as the genes had been deleted from the genome and could not be recreated by the parasite. (Science Daily)
Towards Malaria 'Vaccine': Discovery Opens The Door To Malaria-prevention Therapies Aug 24, 2009
23, 2009) Malaria kills anywhere from one to three million people around the world annually and affects the lives of up to 500 million more. Yet until now, scientists did not fully understand exactly how the process that caused the disease's severe hallmark fevers began. (Science Daily)
Malaria vaccine - the promise the reality Aug 7, 2009
Malaria vaccine - the promise the reality ... So much for the failures of prophylactic medications, we now see a knight, coming to the rescue, mounted on a white horse, armed with a syringe loaded with malaria vaccine ... The Gates Foundation is reported to have committed to date, a total of two hundred and fifty million United States dollars ($250,000,000) for research on a malaria vaccine. (Ghana Web, Ghana)
Mosquitoes used to deliver malaria vaccine Jul 30, 2009
"Malaria vaccines are moving from the laboratory into the real world," Dr. Carlos Campbell wrote in an editorial accompanying the study in Thursday's New England Journal of Medicine. He works for PATH, the Program for Appropriate Technology in Health, a Seattle-based global health foundation. (MSNBC -- Health)
Full Story » Jul 30, 2009
Mosquitoes deliver malaria 'vaccine' through bites - Yahoo. Search Type Choose a search type from the items below. (Yahoo News -- Technology)
PATH Malaria Vaccine Initiative and Crucell to test new malaria vaccine approach Jul 29, 2009
LEIDEN, The Netherlands, July 29, 2009 The US-based PATH Malaria Vaccine Initiative (MVI), the United States Agency for International Development (USAID) Malaria Vaccine Development Program (MVDP), and Dutch biopharmaceutical company Crucell N.V. today announced a collaboration to accelerate development of a promising type of malaria vaccine ... Dr. Jaap Goudsmit, Chief Scientific Officer at Crucell, commented, "This agreement is a strong validation of Crucell's malaria vaccine approach. We... (EurekAlert! -- Business News)
Malaria vaccine will be a first Jul 29, 2009
THE first malaria vaccine to use the whole parasite, developed by Australian researchers, will be tested on humans early next year in the US.. The live vaccine, which will be used on a dozen volunteers in Maryland in February, has been created by genetically altering the parasite so it is unable to get into the blood stream, where it does the damage. (Sydney Morning Herald -- Australia)
GSK launches trial on malaria vaccine Jun 18, 2009
GlaxoSmithKline launches trial on malaria vaccine - Triangle Business Journal ... GlaxoSmithKline launches trial on malaria vaccine ... has launched a phase III clinical trial for a potential malaria vaccine, which contains a component developed by. (Raleigh Triangle Business Journal, NC)
Nigeria: Crisis of National Healthcare Jun 18, 2009
In 2005 he began funding research into malaria vaccine, which was scheduled to be completed in 2011. But my fear is that the multi-nationals who are feeding fat from the farmland of malaria would not want it exterminated by vaccine. (allAfrica.com)
Quintiles opens Ghana operation Jun 17, 2009
The company says the office in Accra, Ghana, will immediately facilitate monitoring of a large malaria vaccine study now under way. The office will be based at the at the. (Raleigh Triangle Business Journal, NC)
Tanzania: Malaria Vaccine Enters Final Tests Jun 5, 2009
com: Tanzania: Malaria Vaccine Enters Final Tests (Page 1 of 1) ... Tanzania: Malaria Vaccine Enters Final Tests ... Hopes that a malaria vaccine could be widely available by 2012 have risen with the start last week (26 May) of phase III trials of the world's most advanced candidate. (allAfrica.com)
Institutional Inertia May 27, 2009
Mr. Robert Desowitz, amedical research entomologist in his book, MALARIA CAPERS says, the search fora malaria vaccine has gone on for generations, and none will ever be found, tobe effective. This research he says is for the sole purpose of gettinggrant money for universities, from wealthy individuals, foundations andgovernments. (Ghana Web, Ghana)
Ghana: Study On Efficacy of Malaria Vaccine Soon May 9, 2009
com: Ghana: Study On Efficacy of Malaria Vaccine Soon (Page 1 of 1) ... Ghana: Study On Efficacy of Malaria Vaccine Soon ... A study on how many mild and severe malaria cases could be prevented by the candidate malaria vaccine, known as RTSS, being tried, is to commence next month. (allAfrica.com)
Biotech nonprofits immune to recession for now May 8, 2009
PATH Malaria Vaccine Institute, in Bethesda, is linking with Rockville-based Sanaria to launch its first human trials of a malaria vaccine. Sanaria hired two more staffers in the last week and is planning another modest bump in head count, all the while mapping out a potential Maryland site for a new manufacturing facility in the next two years. (Washington Business Journal, DC)
A to Z of malaria Apr 30, 2009
V is for Vaccine Despite intensive research, no effective malaria vaccine has been developed to date. But according to a report in April's New Scientist journal, a unique vaccine taken from the saliva of infected mosquitoes has received approval from the U.S. Food and Drug Administration to be tested in people. (CNN -- International)
Phase 1 trial of whole-parasite malaria vaccine to begin Apr 28, 2009
FDA approval for testing in humans watershed moment for unique malaria vaccine approach. ROCKVILLE, Maryland, April 23, 2009 In a move that highlights the strength of public-private collaboration in tackling international health challenges, the Maryland-based company Sanaria Inc., with support from the PATH Malaria Vaccine Initiative (MVI), has initiated a Phase 1 clinical trialthe first tests in adult volunteersof its unique malaria vaccine ... Unlike other malaria vaccine candidates,... (EurekAlert! -- Business News)
